Member Info for martinu

Just checked Amazon India. A bit of a blunt instrument but none of the LightLife products say sold even as few as 50+ month.

Very remiss of me, but I had forgotten that Aug update included unaudited YE figures: rev £4.5-4.8m, EBITDA loss of £0.2-0.4m, cash £4.8m. So I don't expect much on that score. Whether we will get post YE numerical guidance is debatable.

And never mind which auditing regs they follow, the same update said,

"In the meantime, it [SBTX] will report any material information and information of potential interest to shareholders via the RNS system."

Of potential interest!!! I should coco.

Opti seems to be really struggling based on (alleged) selling of stake in SBTX.

Agreed.

AS, thanks for helpful response.

I think this has been mentioned, but in case not. Is it possible SBTX made a cash saving on acquisition earn out, it Dermatonics/ BTS* revenues missed targets? *Sorry can't remember if one or both selling price was subject to performance add on.

It all helps.

It does seem a bit desperate

Advfn and LsE are not in alignment re trades. Adv have all trades as buys. Lse has 7.10p trades as sales.

Me , for one.

Sorry , up 30% not over.

Good Q3 update. Almost £2m rev for 9 months. Up over 30%. Gross margin down slightly 54% from 58%. Small stock write down.

4th of 10. Led, headed, weakened. Story of our lost potential?

AS, possibly a Slim chance, though I wouldn't be too Sweet on him, but might run Well if he's Lean and ready to Go.

Rank, I assume S'drug will have terms for when to pay SBTX. Eg 30/60 days. At what point does the clock start ticking on this. On receipt of goods by S'drug?

As a matter of interest, do we think Dermatonics are likely to get their earnout this time around?

Was 8th Oct (Tues) last year. So possibly tomorrow or soon.

😔

Another Director buy of around £10k. Keeping faith.

Very interesting... Fair play . Putting Ashman to shame on SBTX.